Articles tagged with “generative-ai”

Examine the Novo Nordisk and OpenAI partnership to understand enterprise AI strategy in pharma. Explore generative AI applications in drug R&D and manufacturing

Analyze the $2.75B partnership between Eli Lilly and Insilico Medicine. Understand how generative AI impacts pharma R&D strategy and drug commercialization.

Analyze Earendil Labs' $787M funding and its implications for AI biologics. This educational report examines pharma AI investments and protein drug discovery.

A factual comparison of ChatGPT Enterprise vs Claude Enterprise. Analyze context windows, compliance controls, model capabilities, and enterprise pricing.

An educational guide detailing prompt strategies for ChatGPT and Claude in biotechnology. Covers prompt engineering techniques, model comparisons, and examples.

Explore Ironclad AI capabilities in contract lifecycle management. This deep dive explains agentic architecture, AI Assist, and generative legal tech tools.

Examine the systemic causes of enterprise AI rollout failures. This report analyzes how poor data readiness, flawed integration, and overhype impact AI ROI.

Examine how generative AI is transitioning from experimental tools to core AI-native workflow software in legal, regulatory, and clinical research operations.

Examine the implementation of AI prompt libraries in pharmaceutical workflows. Review prompt engineering techniques, regulatory compliance, and R&D applications

Learn how to deploy ChatGPT Enterprise in regulated GxP environments. This guide covers FDA compliance, 21 CFR Part 11, system validation, and data integrity.

Examine Sanofi's enterprise AI strategy to understand what AI at scale means in pharma. Learn how AI is integrated across biopharma R&D and manufacturing.

Learn how agentic AI in pharma transitions from pilot stages to production. Explore autonomous multi-agent systems, clinical use cases, and regulatory impacts.

Learn about the impact of AI agents on B2B productivity in 2026. This analysis details enterprise adoption trends, case studies, and Anthropic's technical visio

Analyze 2026 strategies for AI-assisted 510(k) submissions. Covers FDA guidance, generative AI tools, and mandatory human oversight protocols.

Analyze FDA Project Elsa, a generative AI system that prioritizes facility inspections by detecting risk patterns in adverse events and regulatory data.

Analyze ChatGPT Deep Research features and RAG technology. Understand agentic workflows, automated literature reviews, and accuracy limitations.

Learn prompt engineering strategies for business teams. Covers zero-shot, few-shot, and chain-of-thought techniques to optimize AI workflows without coding.

Analyze AI in clinical operations: a guide to workflow automation, scribes, and predictive scheduling. Review use cases, tools, and implementation steps.

Compare 2026 enterprise AI models. Evaluate ChatGPT, Claude, Copilot, and Gemini on security, context windows, and performance benchmarks for business adoption.

A technical guide to ChatGPT Enterprise deployment. Covers GPT-5 features, data privacy controls, security protocols, and employee training strategies.

Explore AI automation for Clinical Study Reports (CSRs). Analyze efficiency gains, regulatory compliance, and risks like hallucinations and data security.

Explore FDA Structured Product Labeling (SPL) standards, current automation challenges, and how AI integration optimizes pharmaceutical regulatory workflows.

Compare Veeva AI Agents, ODAIA, and custom copilots. Review deployment timelines, features, and compliance trade-offs for life sciences CRM strategies.

Analyze Veeva's AI roadmap including the transition from Andi to AI Agents. Covers Vault CRM Bot, AI Shortcuts, and the 2026 implementation timeline.

Explore AI in regulatory writing: analysis of drafting efficiency, clinical study reports, and key risks like hallucinations and data privacy compliance.

Analyze AI integration in pharma IT architecture, from R&D to supply chain. Review key data on MLOps, clinical trial efficiency, and FDA guidance.

A 2026 analysis of AI image generation pricing. Compare Google's Gemini & Imagen costs with OpenAI's GPT Image & DALL-E via API and subscription plans.

Learn how Generative AI (GenAI) applies to Medical Affairs in pharma. This guide covers key use cases, compliance guardrails, and the risks of using LLMs.

Learn the SCDC framework for differentiated messaging of high-value AI solutions in life sciences. This guide explains how to tailor content for diverse stakeho

Learn how generative AI and LLMs assist in drafting pharma IND & CTA submissions. This guide covers benefits, risks, GxP compliance, FDA/EMA 2026 joint AI principles, and tools like AutoIND and Narrativa.

Updated 2026 guide to AI-assisted SOP drafting in GxP life sciences. Covers FDA CSA final guidance, FDA-EMA GxP-AI Principles, EU AI Act compliance, EMA Annex 22, and validated AI platforms for pharmaceutical quality management.

An in-depth guide for bench scientists on using LLM copilots in research. Covers GPT-5.2, Gemini 2.5 Pro, Benchling AI, DeepMind co-scientist, real-world performance data, FDA guidance, and 2026 adoption trends.

Updated April 2026 guide to Microsoft Copilot pricing ($30/user add-on, $99 E7 Frontier Suite), licensing changes, April 2026 paywall updates, and qualifying Microsoft 365 plans.

A complete guide to Google Gemini for business plans and pricing (updated April 2026). Learn about Gemini 3.1 Pro, AI Pro/Ultra subscriptions, API costs, Workspace tiers, enterprise models, and real-world use cases.

An in-depth 2026 review of the AlphaSense market intelligence platform. Learn how its AI search, Generative Grid, Financial Data, and Workflow Agents work, plus user reviews, $500M ARR growth, and competitive analysis.

An in-depth analysis of the $300B Oracle-OpenAI cloud computing deal, updated through April 2026. Covers the operational Abilene flagship, $122B OpenAI funding round, Oracle's $523B backlog, Stargate expansion to 7 GW, and IPO preparations.

Explore a data-driven analysis of AI's impact on the 2025 job market for recent graduates. Learn about declining entry-level jobs and new skill demands.

A technical review of Gemini Nano Banana Pro and Nano Banana 2, Google’s AI image models. Learn key specs, pricing, 1M-token context, and applications in life sciences

A technical overview of Claude Opus 4.5 and 4.6, state-of-the-art AI models for coding. Learn their capabilities for software development in healthcare and pharma. Updated February 2026.

Explore how GenAI helps manage pharmaceutical labeling in 2026. Learn to draft local label deviations from a CCDS using AI tools like Veeva AI Agents, and understand FDA-EMA guidance on AI in regulatory compliance.

An evidence-based review of NLP in regulatory labeling (updated April 2026). Learn how AI assists medical writers in drafting Prescribing Information (PI/SmPC), including FDA Elsa, FDA-EMA joint AI principles, and current limitations.

Updated April 2026 analysis of Google's Gemini 3/3.1 Pro AI for healthcare, pharma, and biotech. Covers MedGemma 1.5, HIMSS 2026 deployments, Isomorphic Labs trials, and FDA/EU regulatory developments.

A detailed 2025 comparison of ChatGPT Enterprise vs. Microsoft Copilot. Learn the key differences in features, integration, security, and enterprise AI strategy

An in-depth analysis of the leaders in pharma digital transformation, examining the strategies of companies like AstraZeneca, Roche, Pfizer, Eli Lilly, and Sanofi with AI, generative AI, and cloud technologies — updated with 2025-2026 developments including Lilly's $1B NVIDIA AI lab and FDA AI guidance.

With the rise of vibe coding, many question Agile's future. Our analysis shows Agile remains crucial for managing risks and ensuring quality in AI-driven projec

Explore our 2025 analysis of the top 25 pharmaceutical companies by AI patent filings. Learn who leads in AI R&D, key technology areas, and strategic trends.

Learn to design a ChatGPT workshop for biotech professionals. Updated for GPT-5 and 2026 regulatory frameworks, this guide covers LLM fundamentals, practical use cases, and prompt engineering for life sciences.

Updated 2026 framework for validating generative AI in GxP systems. Covers 21 CFR Part 11, EU Annex 22, ISPE GAMP AI Guide, FDA CSA guidance, and FDA-EMA joint AI principles

Updated guide to Sora 2, OpenAI's AI video model and TikTok-style app. Covers the Disney $1B deal, pricing changes, Android launch, download decline, and competition from Google Veo 3.

Updated 2026: Learn what NVIDIA BioNeMo is and how it accelerates drug discovery. This guide explains its components, latest models (RNAPro, ReaSyn v2), the $1B Lilly partnership, and deployment for generative AI in biopharma.

Analyze the leading data center providers for private AI solutions in 2025-2026. This guide compares on-prem and hybrid infrastructure from AWS, Azure, HPE, Dell, Cisco, VMware/Broadcom, Equinix, and NVIDIA, including Blackwell GPUs and sovereign cloud trends

Explore the Nvidia Blackwell vs Hopper GPU architectures. Key technical differences in tensor cores (FP4/FP6), memory, MLPerf benchmarks, and the road to Rubin — updated for 2026.

Updated 2026 Epic vs Cerner AI comparison. Native AI Charting, CoMET foundation models, Oracle's next-gen EHR, Clinical AI Agent results, and the reshaping ambient scribe market.

Updated 2026 guide to synthetic data in pharmaceutical research. Covers acceptance criteria for fidelity, utility, and privacy, plus latest FDA/EMA AI guidance, EHDS, and diffusion model advances.

An in-depth analysis of Merck's GPTeal platform and expanding AI strategy. Covers the KERMT drug discovery model, Mayo Clinic partnership, CSR automation results, and enterprise-scale LLM deployment across pharma R&D.

An in-depth case study of AstraZeneca's ChatGPT and generative AI implementation, updated for 2026. Covers enterprise strategy, R&D use cases, self-healing supply chains, and agentic AI adoption.

Analysis of AI's role in hospital operations for 2025, covering automated documentation, workflow efficiency, and reduced physician burnout with new data and ca

Learn about AI company Cohere, its enterprise focus, Command family of LLMs, North agent platform, and path to a potential 2026 IPO. Updated with $240M ARR, Tiny Aya models, and latest developments.

Updated for 2026, this article profiles five leading technology companies in healthcare AI—IntuitionLabs, AWS, Google Cloud, IBM, and Microsoft—examining their latest solutions for clinical workflows, AI agents, and patient engagement.

Examines the 2025 AI regulatory frameworks for biopharma in the U.S., EU, U.K., and Canada. Details compliance obligations for GenAI, GxP, and SaMD.

Profiles of leading US researchers and industry pioneers applying generative AI to pharmaceutical R&D, drug discovery, protein design, and clinical trials – updated with 2025-2026 milestones including Phase II/III results, major funding rounds, and regulatory breakthroughs.

Examines the top 10 programming languages by usage and popularity in the context of AI-assisted coding, analyzing AI tool support (Copilot, Cursor, Claude Code, Amazon Q Developer) and ecosystem maturity with 2025-2026 data.

An analysis of the core technologies and design philosophies of Wolfram Alpha (symbolic AI) and ChatGPT (generative AI), detailing their key differences. Updated for GPT-5.2, Wolfram Language 14.3, and the transition from plugins to Custom GPTs.

An overview of AI applications in the pharmaceutical sector, from generative AI to ML. Explains key IT management challenges like data, compliance, and security.

Explore how generative AI is applied in mRNA vaccine development, using Moderna and Pfizer's COVID-19 vaccine as a case study to understand rapid immunization advancements.

Explore ChatGPT as a Generative AI and Large Language Model. Learn its core GPT architecture, Transformer backbone, and how it processes language.

This guide details a structured approach for Generative AI adoption in life sciences, covering strategy, governance, technology, training, and ethical considerations.

This article lists 10 free generative AI courses for pharmaceutical professionals. Learn LLMs, prompt engineering, and AI applications in drug R&D.

A comprehensive exploration of generative AI proof of concepts in pharmaceutical research, examining real-world applications, implementation strategies, and measurable outcomes across the drug development pipeline.

A comprehensive analysis of how pharmaceutical and biotech companies are leveraging NVIDIA's latest H100 and Blackwell GPUs to accelerate drug discovery, protein structure prediction, and AI-driven research, with detailed case studies from leading companies.